Bendamustine in advanced multiple myeloma previously treated with bortezomid and lenalidomide containing regimen

被引：0
|
作者：
Lehenbauer-Dehm, S. [1 ]
Alex, M. [1 ]
Pecher, G. [1 ]
Blau, I [2 ]
Eucker, J. [1 ]
Possinger, K. [1 ]
Scholz, C. [1 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Charite Campus Benjamin Franklin, Berlin, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [41] DIARRHEA INCIDENCE IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE AND POMALIDOMIDE
    Capecchi, M.
    Corradini, P.
    Montefusco, V.
    HAEMATOLOGICA, 2016, 101 : 795 - 796
  • [42] Thromboprophylaxis in Multiple Myeloma Patients Treated with Lenalidomide - a Systematic Review
    Al-Ani, Fatimah
    Louzada, Martha L.
    Bastida Bermejo, Jose Maria
    Victoria Mateos, Maria
    BLOOD, 2015, 126 (23)
  • [43] Infectious Complications in Advanced Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide (Revlimid+/- Corticosteroids).
    Kukreti, Vishal
    Masih-Khan, Esther
    Dean, Saima
    Kumar, Deepali
    Mikhael, Joseph R.
    Trudel, Suzanne
    Reece, Donna E.
    Chen, Christine
    BLOOD, 2009, 114 (22) : 1123 - 1123
  • [44] Selinexor, Daratumumab and Dexamethasone for Patients with Multiple Myeloma Previously Treated with Lenalidomide at First Relapse: A Real-World Study
    Zhai, Yingying
    Yan, Lingzhi
    Jin, Song
    Shang, Jingjing
    Shi, Xiaolan
    Yao, Weiqin
    Yan, Zhi
    Yan, Shuang
    Wu, De-pei
    Fu, Chengcheng
    BLOOD, 2023, 142
  • [45] Analysis of efficacy and safety of POM as a replacement therapy for lenalidomide for relapsed/refractory multiple myeloma pts refractory to a lenalidomide-containing combination regimen.
    Berenson, James R.
    Cohen, Alexa
    Spektor, Tanya M.
    Lashkari, Ashkan
    Mackintosh, Roy
    Bessudo, Alberto
    Robinson, Michael Oren
    Jhangiani, Haresh S.
    Gabrail, Nashat Y.
    Nakhoul, Ibrahim
    Kubba, Samir V.
    Neidhart, Jeffrey D.
    Maluso, Tina
    Swift, Regina A.
    Vescio, Robert A.
    Eshaghian, Shahrooz
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Bendamustine, thalidomide and dexamethasone is an effective salvage regimen for advanced stage multiple myeloma - response to Grey-Davies et al
    Ramasamy, Karthik
    Schey, Stephen
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (04) : 555 - 555
  • [47] Selinexor for the treatment of patients with previously treated multiple myeloma
    Mo, Clifton C.
    Jagannath, Sundar
    Chari, Ajai
    Nooka, Ajay K.
    Lonial, Sagar
    Siegel, David
    Biran, Noa
    Gasparetto, Cristina
    Bahlis, Nizar J.
    Richardson, Paul
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (08) : 697 - 706
  • [48] Use of Daratumumab in Patients With Previously Treated Multiple Myeloma
    Patel, Ashwin P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14)
  • [49] Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma
    Huang, Shang-Xiao
    Luo, Peng-Hui
    Wang, Han-Lei
    Mo, Dun-Chang
    Huang, Jian-Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14) : 2667 - 2668
  • [50] Bendamustine and prednisone in combination with bortezomib in the treatment of patients with advanced multiple myeloma
    Poenisch, W.
    Bourgeois, M.
    Wang, S.
    Jaekel, N.
    Heyn, S.
    Braunert, L.
    Rohrberg, R.
    Hurtz, H.
    Hoffmann, F.
    Schwarzer, A.
    Becker, C.
    Al Ali, H.
    Niederwieser, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 171 - 171
12345